Projects per year
Personal profile
Research interests
- Pathogenesis of atherosclerosis
- Treatment of increased cardiovascular risk
specialisation
Collaborations and top research areas from the last five years
Projects
- 2 Active
-
Stroes E.S.G.: Novel anti-atherogenic strategies targeting the vessel wall
Amraoui, F., Bakker, G., van der Bel, R., van den Boogert, M., Bouter, K., Bruikman, C., van Capelleveen, J., Eeftinck Schattenkerk, D., Emans, T., Gilijamse, P., de Groot, P., Hartgers, M., Hartstra, A., Hoogeveen, R., Kootte, R., Lameijer, M., Reeskamp, R., Sabry, A., Sandberg, M., Sjouke, B., Smits, L., Stiekema, L., Surendran, P., Udayappan, S., Verbeek, R., Verweij, S., Zhang, Q., Zheng, K. H., Stroes, E., van den Born, B. H., Dallinga - Thie, G., Hovingh, G., Kastelein, J., Mulder, W., Nederveen, A. & Nieuwdorp, M.
1/06/2008 → …
Project: Research
-
Kastelein J.J.P.: Vascular Medicine
Luirink, I., Roelants, R., Kastelein, J., Dallinga - Thie, G., Defesche, J., Hovingh, G. & Pinto - Sietsma, S.
1/01/2006 → …
Project: Research
-
Correction to: The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial (Nature Medicine, (2023), 29, 7, (1782-1792), 10.1038/s41591-023-02427-z)
Bhatt, D. L., Bays, H. E., Miller, M., Cain, J. E., Wasilewska, K., Andrawis, N. S., Parli, T., Feng, S., Sterling, L., Tseng, L., Hartsfield, C. L., Agollah, G. D., Mansbach, H. & ENTRIGUE Principal Investigators, 2024, (E-pub ahead of print) In: Nature medicine.Research output: Contribution to journal › Comment/Letter to the editor › Academic
Open Access -
Evolocumab in paediatric heterozygous familial hypercholesterolaemia: cognitive function during 80 weeks of open-label extension treatment
Santos, R. D., Ruzza, A., Wang, B., Maruff, P., Schembri, A., Bhatia, A. K., Mach, F., Bergeron, J., Gaudet, I., Pierre, J. S., Kastelein, J. J. P., Kees Hovingh, G., Wiegman, A., Gaudet, D. & Raal, F. J., 1 Feb 2024, In: European journal of preventive cardiology. 31, 3, p. 302-310 9 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Adherence to statin treatment in patients with familial hypercholesterolemia: A dynamic prediction model
Cupido, A. J., Hof, M. H., de Boer, L. M., Huijgen, R., Stroes, E. S. G., Kastelein, J. J. P., Hovingh, G. K. & Hutten, B. A., 1 Mar 2023, In: Journal of clinical lipidology. 17, 2, p. 236-243 8 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access2 Citations (Scopus) -
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients
CLEAR Outcomes Investigators, 13 Apr 2023, In: The New England journal of medicine. 388, 15, p. 1353-1364 12 p.Research output: Contribution to journal › Article › Academic › peer-review
174 Citations (Scopus) -
Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients
Nissen, S. E., Menon, V., Nicholls, S. J., Brennan, D., Laffin, L., Ridker, P., Ray, K. K., Mason, D., Kastelein, J. J. P., Cho, L., Libby, P., Li, N., Foody, J., Louie, M. J. & Lincoff, A. M., 11 Jul 2023, In: JAMA. 330, 2, p. 131-140 10 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access28 Citations (Scopus)
Datasets
-
Supplementary Material for: Icosabutate, a Structurally Engineered Fatty Acid, Improves the Cardiovascular Risk Profile in Statin-Treated Patients with Residual Hypertriglyceridemia
Kastelein, J. (Contributor), Hallén, J. (Creator), Vige, R. (Creator), Fraser, D. A. (Creator), Zhou, R. (Creator), Hustvedt, S. O. (Creator), Orloff, D. G. (Creator), Bays, H. E. (Creator) & Hallén, J. (Creator), Karger Publishers, 2016
DOI: 10.6084/m9.figshare.5129680.v1, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Icosabutate_a_Structurally_Engineered_Fatty_Acid_Improves_the_Cardiovascular_Risk_Profile_in_Statin-Treated_Patients_with_Residual_Hypertriglyceridemia/5129680/1
Dataset
-
Supplementary Material for: Icosabutate, a Structurally Engineered Fatty Acid, Improves the Cardiovascular Risk Profile in Statin-Treated Patients with Residual Hypertriglyceridemia
Kastelein, J. (Contributor), Hallén, J. (Creator), Vige, R. (Creator), Fraser, D. A. (Creator), Zhou, R. (Creator), Hustvedt, S. O. (Creator), Orloff, D. G. (Creator), Bays, H. E. (Creator) & Hallén, J. (Creator), Karger Publishers, 2016
DOI: 10.6084/m9.figshare.5129680, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Icosabutate_a_Structurally_Engineered_Fatty_Acid_Improves_the_Cardiovascular_Risk_Profile_in_Statin-Treated_Patients_with_Residual_Hypertriglyceridemia/5129680
Dataset